Pharmaceutical composition containing a xanthine derivative

US4225607A · kind A · utility

Assignee

• Johann A. Wulfing · DE

Inventors

• Joachim Goring · Gronau, DE
• Peter P. Ochlich · Gronau, DE

Key dates

• Filing date: May 14, 1979
• Grant date: Sep 30, 1980
• Expiry date: May 14, 1999

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/52
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

It has been found that 1,3-di-n-butyl-7-(2-oxopropyl)xanthine is a particularly effective agent for increasing oxygen partial pressure and contractility in ischaemic and skeletal muscle. Pharmaceutical compositions containing 1 to 30 mg of this agent are described.